Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3285 | Recombinant Human Interferon α2b Spray Wiki | 1.00 |
drug344 | Arbidol Hydrochloride Granules Wiki | 1.00 |
drug658 | Bromhexine Hydrochloride Tablets Wiki | 1.00 |
Navigate: Correlations HPO
There is one clinical trial.
Following the acute phase of COVID, some patients may have sequelae, such as breathing difficulties or malnutrition. We hypothesize that a functional and respiratory rehabilitation program associated with personalized nutritional care will improve quality of life, physical performance and respiratory capacities and will decrease the prevalence of malnutrition among those patients.
Description: Physical component score of the Short-Form 36 health survey between the beginning and the end of the rehabilitation program (from 0 to 100; highers scores mean better outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program on COVID patients's quality of life Time: 1 monthDescription: Number of repeated chair rises during 3 minutes
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Physical capacities Time: 1 monthDescription: Aerobic physical capacity using Eval-DM software
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Physical capacities Time: 1 monthDescription: Modified Medical Research Council scale (mMRC) (from 0 to 4, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Time: 1 monthDescription: Modified Medical Research Council scale (mMRC) (from 0 to 4, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Time: 3 monthsDescription: Borg scale (from 0 to 10, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Time: 1 monthDescription: Borg scale (from 0 to 10, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Respiratory capacities Time: 3 monthsDescription: Barthel scale (from 0 to 100, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Functional capacities Time: 1 monthDescription: Barthel scale (from 0 to 100, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Functional capacities Time: 3 monthsDescription: Weight loss
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 1 monthDescription: Weight loss
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 3 monthsDescription: Body mass index
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 1 monthDescription: Body mass index
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 3 monthsDescription: Muscular mass by brachial circumference or grip strength
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 1 monthDescription: SEFI® score (from 0 to 10, highers scores mean better outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 1 monthDescription: SEFI® score (from 0 to 10, highers scores mean better outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Malnutrition prevalence rate using GLIM malnutrition diagnostic criteria Time: 3 monthsDescription: Mortality rate
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of mortality Time: 1 monthDescription: Mortality rate
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of mortality Time: 3 monthsDescription: Score of the Short-Form 36 health Survey (from 0 to 100, highers scores mean better outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Time: 1 monthDescription: Score of the Short-Form 36 health Survey (from 0 to 100, highers scores mean better outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Time: 3 monthsDescription: EuroQol 5 Dimensions 5 Levels surveys (from 0 to 1, highers scores mean better outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Time: 1 monthDescription: Proportion of patients returning to a professional activity
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Time: 1 monthDescription: Proportion of patients returning to a professional activity
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Quality of life Time: 3 monthsDescription: Hospital and Anxiety Depression Scale (from 0 to 42, highers scores mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Time: 1 monthDescription: Hospital and Anxiety Depression Scale (from 0 to 42, highers scores mean worse outcome
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Time: 3 monthsDescription: Pichot asthenia scale (from 0 to 32, highers mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Time: 1 monthDescription: Pichot asthenia scale (from 0 to 32, highers mean worse outcome)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Anxiety and depression Time: 3 monthsDescription: Number of consultations with the healthcare professionals
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Time: 1 monthDescription: Number of consultations with the healthcare professionals
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Time: 3 monthsDescription: Rehospitalisation rate (all causes)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Time: 1 monthDescription: Rehospitalisation rate (all causes)
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Healthcare consumption Time: 3 monthsDescription: Incremental cost-effectiveness ratio
Measure: Impact of a multidisciplinary and personalized rehabilitation program in terms of Medico-economic evaluation Time: 3 monthsDescription: Satisfaction questionnaire with open-ended questions (no specific scale is available)
Measure: Patient's opinion concerning the rehabilitation program Time: 3 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports